Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-04-12 | Initiator Pharma | Initiator Pharma’s pudafensine preclinical pharmacology results published in the British Journal of Pharmacology | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-12 | Initiator Pharma | Initiator Pharmas prekliniska farmakologiska resultat med pudafensine publiceras i British Journal of Pharmacology | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-26 | Penser Access by Carnegie | Penser Access by Carnegie: Intervju med Initiator Pharma - Carnegie Investment Bank - 26 feb 2024 | Pressreleaser | Visa Stäng |
|
||||
2024-02-23 | Redeye | Redeye: Initiator Pharma - Q4 2023 – Breathing optimism | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-23 | Initiator Pharma | INITIATOR PHARMA: BOKSLUTSKOMMUNIKÉ 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-23 | Initiator Pharma | INITIATOR PHARMA: YEAR END REPORT 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-02-21 | Initiator Pharma | MAC Clinical Research konverterar sin fordran till aktier i Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-21 | Initiator Pharma | MAC Clinical Research converts its receivable into shares in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-23 | Initiator Pharma | Issuance of new shares and directed share buyback, as well as the sale of shares in connection with the long-term incentive program for 2021 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-23 | Initiator Pharma | Nyemission och riktat aktieåterköp samt försäljning av aktier i samband med det långsiktiga incitamentsprogrammet för 2021 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Initiator Pharma | Initiator Pharma utvidgar sin position till en bredare franchise inom sexuell hälsa och intensifierar affärsutvecklingsarbetet | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-08 | Initiator Pharma | Initiator Pharma expands its position to a broader Sexual Health Franchise and intensifies its business development efforts | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-13 | Penser Access | Penser Access: Positiv utveckling - mer på agendan i år - Initiator Pharma | Pressreleaser | Visa Stäng |
|
||||
2023-11-10 | Redeye | Redeye: Initiator Pharma Q3 - A historical quarter | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-10 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR TREDJE KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-11-10 | Initiator Pharma | INITIATOR PHARMA: Q3 2023 REPORT | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-18 | Initiator Pharma | Initiator Pharma presenterar på BioStock Life Science Summit den 25 oktober | Pressreleaser | Visa Stäng |
|
||||
2023-10-10 | Redeye | Redeye: Initiator Pharma - Positive Phase IIb results | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-09 | Penser Access | Penser Access: Levererar positiva resultat - Initiator Pharma | Pressreleaser | Visa Stäng |
|
||||
2023-10-09 | Penser Access | Penser Access: Interview with Initiator Pharma - Erik Penser Bank - Oct 9th 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-10-06 | Initiator Pharma | Initiator Pharma reports positive statistically significant and clinically relevant Phase IIb efficacy data with pudafensine | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-06 | Initiator Pharma | Initiator Pharma rapporterar positiva, statistiskt signifikanta och kliniskt relevanta fas IIb-effektdata för pudafensine | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-25 | Initiator Pharma | Utnyttjande i Initiator Pharmas incitamentsprogram LTI2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-25 | Initiator Pharma | Result of incentive program LTI2023 in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-22 | Penser Access | Penser Access: Interview with Initiator Pharma - Erik Penser Bank - Sep 21st 2023 | Pressreleaser | Visa Stäng |
|
||||
2023-09-19 | Initiator Pharma | Initiator Pharma announces indication expansion – clinical drug candidates active in models of female sexual dysfunction | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-09-19 | Initiator Pharma | Initiator Pharma meddelar indikationsutvidgning av båda sina kliniska läkemedelskandidater till kvinnor med sexuell dysfunktion | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Redeye | Redeye: Initiator Pharma Q2 2023 - Development progres | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR ANDRA KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Initiator Pharma | INITIATOR PHARMA: Q2 2023 REPORT | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-08-09 | Initiator Pharma | Initiator Pharma obtains IP2018 patent in Europe for treatment of Erectile Dysfunction and Depression | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-09 | Initiator Pharma | Initiator Pharma erhåller patent i Europa för IP2018 mot erektil dysfunktion och depression | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Initiator Pharma | Initiator Pharma announces positive results from pudafensine Phase I pharmacokinetic trial | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Initiator Pharma | Initiator Pharma meddelar positiva resultat från farmakokinetisk fas I-studie med pudafensin | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-05 | Initiator Pharma | Slutförande av aktieåterköpsprogram i Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-05 | Initiator Pharma | Finalization of share buyback program in Initiator Pharma | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-29 | Initiator Pharma | Initiator Pharma completes recruitment in Phase IIb trial with pudafensine (IP2015) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-29 | Initiator Pharma | Initiator Pharma slutför rekryteringen i fas IIb-studie med pudafensine (IP2015) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-21 | Initiator Pharma | Emission av nya aktier, återköp och försäljning av aktier i samband med långsiktigt incitamentsprogram för 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-21 | Initiator Pharma | Issuance of new shares, share buyback and sale of shares in connection with long term incentive program for 2022 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-14 | Penser Access | Penser Access: Positiva resultat stärker caset - Initiator Pharma | Pressreleaser | Visa Stäng |
|
||||
2023-06-05 | Initiator Pharma | Initiator Pharma reports dose-dependent significant efficacy of IP2018 in the placebo-controlled Phase IIa clinical trial of Erectile Dysfunction | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-06-05 | Initiator Pharma | Initiator Pharma rapporterar positiva dosberoende och signifikanta effektdata i den kliniska fas IIa-studien med IP2018 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-31 | Initiator Pharma | BioStock Life Science Spring Summit med Initiator Pharma | Pressreleaser | Visa Stäng |
|
||||
2023-05-31 | Initiator Pharma | BioStock Life Science Spring Summit with Initiator Pharma | Pressreleaser | Visa Stäng |
|
||||
2023-05-30 | Initiator Pharma | Initiator Pharma erhåller det internationella generiska namnet pudafensine för IP2015 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-30 | Initiator Pharma | Initiator Pharma’s IP2015 obtains the International Nonproprietary Name pudafensine | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-26 | Initiator Pharma | Initiator Pharma A/S - Resolutions of the annual general meeting 2023 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Redeye | Redeye: Initiator Pharma Q1 report - Countdown to readouts | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Redeye: Initiator Pharma Q1 report – Countdown to readoutsRedeye provides a research update following the Q1 report published by Initiator Pharma earlier today. Overall, the report did not contain any significant surprises and was in line with our expectations. Accordingly, we reiterate our fair value range with a base case valuation of SEK13.5 as we look forward to the readouts from the company’s three ongoing clinical trials expected later this year. Read more and download the Research Update. Follow companies at Redeye to receive the latest equity research within Life Science and Technology. This is a press release from Redeye – Research Powered Investment Banking. www.redeye.se/ |
||||
2023-05-05 | Initiator Pharma | INITIATOR PHARMA: RAPPORT FÖR FÖRSTA KVARTALET 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-05 | Initiator Pharma | INITIATOR PHARMA: Q1 2023 REPORT | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-03 | Initiator Pharma | Initiator Pharma A/S | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Initiator Pharma | Annual report and Remuneration report 2022 for Initiator Pharma A/S | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-05-02 | Initiator Pharma | Årsredovisning och ersättningsrapport 2022 för Initiator Pharma A/S | Rapporter | Ladda ner | Visa Stäng |
|